2/3
Katherine Unger Baillie
Senior Science News Officer
kbaillie@upenn.edu
Cancer Research
Machine learning-triggered reminders improve end-of-life care for patients with cancer
Machine learning-triggered reminders improve end-of-life care for patients with cancer
The rates of advanced care planning conversations quadrupled, while potentially harmful therapy at end of life decreased by 25% in large randomized study.
CAR T cell therapy may eliminate tumor cells missed by surgery
CAR T cell therapy may eliminate tumor cells missed by surgery
The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.
The Jin Lab taps into a key cell for cancer research
The Jin Lab taps into a key cell for cancer research
The lab, led by Chengcheng Jin, an assistant professor of cancer biology and microbiology, is investigating how the immune system co-evolves with tumors during cancer progression.
FDA approves ‘glowing tumor’ imaging drug to aid lung cancer surgery
FDA approves ‘glowing tumor’ imaging drug to aid lung cancer surgery
The injectable diagnostic, Cytalux, binds to cancerous tissue and glows, making it easier for surgeons to remove tumors completely while sparing healthy tissue.
Advances in cancer research
Advances in cancer research
Recent research shows promise in a novel CAR T therapy after cancer relapse, and a novel treatment for multiple myeloma.
How the perception of risks and benefits influence cancer clinical trial withdrawal outcomes
How the perception of risks and benefits influence cancer clinical trial withdrawal outcomes
A new study from the School of Nursing examines the association between patients’ perceived benefits and burdens of research participation and withdrawal.
Study shows promise of new anti-KRAS drug for pancreatic cancer
Study shows promise of new anti-KRAS drug for pancreatic cancer
A small molecule inhibitor that attacks the difficult cancer-causing gene mutation KRAS successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer.
HPV-related cancers are on the rise in men
HPV-related cancers are on the rise in men
Recent CDC data show that roughly four of every 10 cases of HPV-induced cancer now occur in men. Penn Medicine research has found that differences in levels of a particular HPV protein may inform treatment.
CAR T cell therapy reaches beyond cancer
CAR T cell therapy reaches beyond cancer
Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.
Home health care—a crucial edge for the future of medicine
Home health care—a crucial edge for the future of medicine
Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital.
Media Contact
In the News
Philadelphia Inquirer
Penn Medicine is going all in on proton therapy, a costly treatment that is unproven for most common cancers
A profile examines Penn Medicine’s commitment to the advancement of proton therapy, a new radiation cancer treatment, with remarks from James Metz and Justin E. Bekelman of the Perelman School of Medicine.
FULL STORY →
Philadelphia Inquirer
For breast cancer patients, Penn researchers are comparing costly proton therapy with standard radiation
The Perelman School of Medicine’s Justin E. Bekelman is leading a $12 million study to compare the effects of proton therapy and standard radiation treatment on breast cancer.
FULL STORY →
Nature
The race to supercharge cancer-fighting T cells
Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies.
FULL STORY →
The Washington Post
Another Crispr first: New treatment wipes out teen’s cancer
Bruce Levine of the Perelman School of Medicine says that the latest results of Crispr gene editing in a cancer patient have showcased the best possible clinical outcome thus far.
FULL STORY →
NPR
CRISPR gene-editing may boost cancer immunotherapy, new study finds
Carl June of the Perelman School of Medicine says that off-the-shelf CAR-T cell therapies using CRISPR would be a game-changer.
FULL STORY →
CBS News
Dogs may hold key to treating cancer in humans
A study by Nicola Mason of the School of Veterinary Medicine and colleagues found that an experimental immunotherapy treatment using genetically modified listeria could extend the life expectancy of dogs with cancer.
FULL STORY →